🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT04291378
Recruiting Not applicable

The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer

NCT04291378 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2020-06-01
Last updated
2020-10-08

Condition(s) studied

Early Breast CancerRadiation Associated Cardiac Failure

Investigational drug(s) / intervention(s)

Proton versus photon radiation therapy

Proton versus photon radiation therapy: The intervention is proton radiation therapy versus photon radiation therapy

Study summary

The majority of early breast cancer patients are treated with adjuvant radiation therapy (RT) as part of their multimodal therapy. The aim of the RT is to lower the risk of local, regional and distant failure and improve survival. Modern RT is been provided with photon therapy. Now, more proton therapy facilities are opened, including in Denmark. Proton RT may have the potential to cause lower dose to heart and lung during breast RT. This trial will randomise patients between standard photon RT versus experimental proton RT. The primary endpoint is 10 year risk of heart disease.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient operated for early breast cancer with indication for radiation therapy, where standard planning shows a mean heart dose 4 Gy or more and/or a V20 lung of 37% or more. * Boost (breast, chest wall and nodal), breast reconstruction (any type, except implants with metal), connective tissue disease, post-operative surgical complications, any breast size and seromas are allowed * Patient with previous non-breast malignancy is accepted if the patient has been without disease minimum 5 years, and the treating oncologist estimates a low risk of recurrence. * Life expectancy minimum 10 years Exclusion Criteria: * previous breast cancer/ductal carcinoma in situ, * Previous RT to the chest region * Pregnant or lactating * Conditions indicating that the patient cannot go through the RT or follow up * Patients with Pacemaker or defibrillator are excluded until a guideline for handling them has been developed at the DCPT * Unknown non-tissue implants upstream of the target volume. NB. all such non-tissue, non-metal objects must be delivered to the DCPT for stopping power determination and evaluation at least a week prior to radiation start. * Metal implants in the radiation area, including metal in implants.

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
Aalborg University Hospital Aalborg Denmark Recruiting
Aarhus University Hospital Aarhus Denmark Recruiting
The Danish Breast Cancer Cooperative Group Copenhagen Denmark Not Yet Recruiting
Rigshospitalet Copenhagen Denmark Recruiting
Herlev Hospital Herlev Denmark Recruiting
Naestved Hospital Næstved Denmark Recruiting
Odense University Hospital Odense Denmark Recruiting
Vejle Hospital Vejle Denmark Recruiting

More Danish Breast Cancer Cooperative Group trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04291378 on ClinicalTrials.gov ↗ ← All trials in Denmark